Literature DB >> 22616579

Total synthesis and biological evaluation of transvalencin Z.

Kathryn M Nelson1, Christine E Salomon, Courtney C Aldrich.   

Abstract

The emerging global epidemic of drug-resistant tuberculosis has created an urgent need to identify novel therapeutic approaches for disease treatment. Transvalencin Z (1) is a natural product from Nocardia transvalensis with relatively potent and selective antimycobacterial activity against Mycobacterium smegmatis, making it an attractive target for structure-activity and mechanism of action studies. The total synthesis of the four possible diastereomers of transvalencin Z was completed (1a-d), and the absolute configurations were defined using chemical synthesis, HPLC retention times, and optical rotation measurements. Surprisingly, none of the transvalencin Z diastereomers exhibited any inhibitory activity against a panel of microbial pathogens, including several species of mycobacteria.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22616579      PMCID: PMC3381897          DOI: 10.1021/np200972s

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  24 in total

1.  Totally drug-resistant tuberculosis in India.

Authors:  Zarir F Udwadia; Rohit A Amale; Kanchan K Ajbani; Camilla Rodrigues
Journal:  Clin Infect Dis       Date:  2011-12-21       Impact factor: 9.079

2.  Transvalencin Z, a new antimicrobial compound with salicylic acid residue from Nocardia transvalensis IFM 10065.

Authors:  Akira Mukai; Toshio Fukai; Yuko Matsumoto; Jun Ishikawa; Yasutaka Hoshino; Katsukiyo Yazawa; Ken-ichi Harada; Yuzuru Mikami
Journal:  J Antibiot (Tokyo)       Date:  2006-06       Impact factor: 2.649

3.  Synthesis and studies of catechol-containing mycobactin S and T analogs.

Authors:  Andrew J Walz; Ute Möllmann; Marvin J Miller
Journal:  Org Biomol Chem       Date:  2007-04-19       Impact factor: 3.876

Review 4.  Natural products, small molecules, and genetics in tuberculosis drug development.

Authors:  Maria-Teresa Gutierrez-Lugo; Carole A Bewley
Journal:  J Med Chem       Date:  2008-04-05       Impact factor: 7.446

Review 5.  Mycobactins: iron-chelating growth factors from mycobacteria.

Authors:  G A Snow
Journal:  Bacteriol Rev       Date:  1970-06

6.  Effects of lysine acetylation in a beta-hairpin peptide: comparison of an amide-pi and a cation-pi interaction.

Authors:  Robert M Hughes; Marcey L Waters
Journal:  J Am Chem Soc       Date:  2006-10-18       Impact factor: 15.419

7.  Isolation and structure of mycobactin T, a growth factor from Mycobacterium tuberculosis.

Authors:  G A Snow
Journal:  Biochem J       Date:  1965-10       Impact factor: 3.857

8.  Synthesis of dideoxymycobactin antigens presented by CD1a reveals T cell fine specificity for natural lipopeptide structures.

Authors:  David C Young; Anne Kasmar; Garrett Moraski; Tan-Yun Cheng; Andrew J Walz; Jingdan Hu; Yanping Xu; Gregory W Endres; Adam Uzieblo; Dirk Zajonc; Catherine E Costello; Marvin J Miller; D Branch Moody
Journal:  J Biol Chem       Date:  2009-07-15       Impact factor: 5.157

9.  Syntheses and biological activity of amamistatin B and analogs.

Authors:  Kelley A Fennell; Ute Möllmann; Marvin J Miller
Journal:  J Org Chem       Date:  2008-01-04       Impact factor: 4.354

10.  A latent oxazoline electrophile for N-O-C bond formation in pseudomonine biosynthesis.

Authors:  Elizabeth S Sattely; Christopher T Walsh
Journal:  J Am Chem Soc       Date:  2008-08-19       Impact factor: 15.419

View more
  1 in total

1.  A mild catalytic synthesis of 2-oxazolines via oxetane ring-opening: rapid access to a diverse family of natural products.

Authors:  Hai Huang; Wen Yang; Zuliang Chen; Zengwei Lai; Jianwei Sun
Journal:  Chem Sci       Date:  2019-08-26       Impact factor: 9.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.